Johnson & Johnson and its subsidiaries have approximately 152,700 employees engaged in research and development, manufacturing, and selling a broad range of healthcare products that focus on human health and well-being.
The Company operates through three segments: Consumer Health, Pharmaceutical, and MedTech, offering products ranging from personal care to innovative medicines and medical devices.
Industries and Markets
The Company operates in the healthcare industry, specifically in pharmaceuticals, medical technology, and consumer health segments focusing on personal care and wellness.
Following the additional separation of the Consumer Health business as Kenvue, the Company is now primarily organized into two reportable segments: Innovative Medicine and MedTech.
Competitive Position
Johnson & Johnson's competitive advantages include its extensive range of products, strong brand recognition, significant investment in research and development, and an established global presence.
They are particularly focused on protecting their intellectual property to support their long-term market position against competitors.
Geographic Presence
The Company conducts business in virtually all countries worldwide, with approximately 43% of its sales occurring outside the United States, including significant markets in Europe, Asia-Pacific, and Africa.
Sales from companies in Europe and the Western Hemisphere, excluding the U.S., contribute operational growth, although both regions have faced currency impacts and some declines.
Key Strategies
Current strategies emphasize innovation and development of differentiated products while responding to evolving healthcare needs, including a focus on climate change and sustainability.
They are also committed to workplace diversity and inclusion to attract and retain skilled talent essential for their growth.
Target Customers
The Company's target customer base includes individual consumers for its consumer health products, as well as enterprises such as hospitals, clinics, and healthcare professionals for its pharmaceutical and medical technology segments.
Products are marketed through eCommerce platforms and retail outlets globally.
Partnerships and Dependencies
The Company relies on numerous key suppliers and third-party manufacturers to produce and distribute its products, making them susceptible to operational disruptions and compliance with regulatory standards.
Internal risks include the reliance on third parties for technology and data management, which expose the company to potential cybersecurity threats.
AI Assistant
JOHNSON & JOHNSON
2025
10 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.